{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:29:39Z","timestamp":1789532979251,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015438","name":"International Society on Thrombosis and Haemostasis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005629","name":"Takeda Pharmaceuticals USA Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005629","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.rpth.2025.103270","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:25:57Z","timestamp":1768868757000},"page":"103270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S4","title":["Optimizing the management of congenital thrombotic thrombocytopenic purpura"],"prefix":"10.1016","volume":"9","author":[{"given":"Melissa F.","family":"Glasner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthil","family":"Sukumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spero R.","family":"Cataland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Scully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.103270_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/jcm10030536","article-title":"Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management","volume":"10","author":"Sukumar","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.rpth.2025.103270_bib2","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103270_bib3","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood-2004-11-4490","article-title":"ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases","volume":"106","author":"Rieger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103270_bib4","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/pbc.24612","article-title":"Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features","volume":"60","author":"Reese","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.rpth.2025.103270_bib5","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","article-title":"Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura","volume":"119","author":"Moatti-Cohen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103270_bib6","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood-2018-11-884700","article-title":"Characterization and treatment of congenital thrombotic thrombocytopenic purpura","volume":"133","author":"Alwan","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103270_bib7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1182\/bloodadvances.2021005760","article-title":"Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura","volume":"6","author":"Borogovac","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103270_bib8","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood-2012-06-433235","article-title":"A second hit for TMA","volume":"120","author":"Miyata","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103270_bib9","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood.2020009801","article-title":"Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura","volume":"137","author":"Tarasco","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103270_bib10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jth.12826","article-title":"Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity","volume":"13","author":"Zafrani","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103270_bib11","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1182\/blood.2021011265","article-title":"Congenital TTP: next stop, acuity and therapy","volume":"137","author":"Scully","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103270_bib12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1182\/asheducation-2018.1.548","article-title":"TTP: long-term outcomes following recovery","volume":"2018","author":"George","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpth.2025.103270_bib13","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3324\/haematol.2019.216796","article-title":"The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017","volume":"104","author":"van Dorland","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2025.103270_bib14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.2019001056","article-title":"Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors","volume":"134","author":"Upreti","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103270_bib15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood-2023-189181","article-title":"Pregnancy-related outcomes in patients with congenital thrombotic thrombocytopenic purpura: post hoc analysis of a retrospective chart review study","volume":"142","author":"Coppo","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103270_bib16","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ajh.23527","article-title":"ADAMTS13 content in plasma-derived factor VIII\/von Willebrand factor concentrates","volume":"88","author":"Peyvandi","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.103270_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2022.100120","article-title":"ADAMTS13 levels in a plasma-derived FVIII concentrate: a potential therapeutic option for patients with congenital thrombotic thrombocytopenic purpura","volume":"9","author":"Mori","year":"2022","journal-title":"Thromb Update"},{"key":"10.1016\/j.rpth.2025.103270_bib18","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jth.15006","article-title":"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103270_bib19","series-title":"StatPearls. Treasure Island (FL)","article-title":"Thrombotic thrombocytopenic purpura evaluation and management","author":"Nu\u00f1ez Zuno","year":"2025"},{"key":"10.1016\/j.rpth.2025.103270_bib20","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.3390\/jcm12103365","article-title":"Current and future therapy, and long-term outcomes in congenital thrombotic thrombocytopenic purpura","volume":"12","author":"Sakai","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.rpth.2025.103270_bib21","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMra1813013","article-title":"Hereditary thrombotic thrombocytopenic purpura","volume":"381","author":"Kremer Hovinga","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103270_bib22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/bjh.15082","article-title":"Comparing transfusion reaction risks for various plasma products\u2014an analysis of 7 years of ISTARE haemovigilance data","volume":"180","author":"Saadah","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103270_bib24","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1056\/NEJMoa2314793","article-title":"Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura","volume":"390","author":"Scully","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103270_bib25","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1016\/j.jtha.2025.06.002","article-title":"2025 Focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura","volume":"23","author":"Zheng","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103270_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1182\/bloodadvances.2023011972","article-title":"Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience","volume":"8","author":"B\u00e9ranger","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103270_bib27","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1182\/bloodadvances.2024013265","article-title":"Recombinant ADAMTS13: an effective rescue therapy for acute cTTP during pregnancy","volume":"8","author":"Dadoun","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103270_bib28","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1182\/blood.2019000962","article-title":"How I treat thrombotic thrombocytopenic purpura in pregnancy","volume":"136","author":"Ferrari","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103270_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","article-title":"Registry collaborators of the UT. Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes","volume":"124","author":"Scully","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103270_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206558","article-title":"Impact of a multidisciplinary team for the management of thrombotic microangiopathy","volume":"13","author":"Uriol Rivera","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2025.103270_bib31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40271-019-00365-y","article-title":"Patient experience with congenital (hereditary) thrombotic thrombocytopenic purpura: a conceptual framework of symptoms and impacts","volume":"12","author":"Oladapo","year":"2019","journal-title":"Patient"},{"key":"10.1016\/j.rpth.2025.103270_bib32","series-title":"StatPearls. Treasure Island","article-title":"Thrombotic thrombocytopenic purpura","author":"Stanley","year":"2025"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925005941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925005941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:36:37Z","timestamp":1773963397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925005941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"alternative-id":["S2475037925005941"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103270","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing the management of congenital thrombotic thrombocytopenic purpura","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103270"}}